By continuing to use Symptoma®, you confirm you accept the cookies. More on
522301 to 522400 most common queries
List represents a sample of symptoms, diseases, and other queries. Updated weekly.
Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO Study.
Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells.
Smoking and cardiovascular disease.
Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.
Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan.
Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease.
Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitis obliterans.
Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model.
Chronic exposure to retroviral vector encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice.
Secondary hyperparathyroidism and renal osteodystrophy in chronic renal failure. Analysis of 195 patients, with observations on the effects of chronic dialysis, kidney transplantation and subtotal parathyroidectomy.
The gene encoding the mouse homologue of the human osteoclast-specific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants.
Sclerostin: current knowledge and future perspectives.
Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature.
Differences in descriptions of Kellgren and Lawrence grades of knee osteoarthritis.
A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation.
Bone abnormalities in latent TGF-[beta] binding protein (Ltbp)-3-null mice indicate a role for Ltbp-3 in modulating TGF-[beta] bioavailability.
Role of Wnts in prostate cancer bone metastases.
Subchondral bone changes in hand and knee osteoarthritis detected by radiography.
[Chronic hyperglycemia, combined with osteosclerosis, hyperazotemia, nanism and congenital malformations].
The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells.
Secreted kinase phosphorylates extracellular proteins that regulate biomineralization.
The genetic transformation of bone biology.
SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.
Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1.
A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.
Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis.
Dimorphic effects of Notch signaling in bone homeostasis.
Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification.
Quantitative studies of naturally occurring murine leukemia virus infection of AKR mice.
Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.
Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging.
cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury.
Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).
The tripartite synapse: roles for gliotransmission in health and disease.
Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats.
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery.
Doublecortin expression levels in adult brain reflect neurogenesis.
Targeting recovery: priorities of the spinal cord-injured population.
Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains.
The injured spinal cord spontaneously forms a new intraspinal circuit in adult rats.
Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury.
Identification of a neural stem cell in the adult mammalian central nervous system.
Reactive astrocytes protect tissue and preserve function after spinal cord injury.
Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord.
Glial inhibition of CNS axon regeneration.
Chondroitinase ABC promotes functional recovery after spinal cord injury.
Acute Coryza, Conjunctivitis, Cough, fever, acute cough, chills, productive cough, chest pain, acute pain
Histamine and cardiac arrhythmias.
Cigarette smoking is a major risk factor for coronary spasm.
Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta.
Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm.
Coronary artery spasm induced in atherosclerotic miniature swine.
Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation.
Why do plaques rupture?
Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study.
A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese.
Angina caused by reduced vasodilator reserve of the small coronary arteries.
Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process.
Endothelium-derived relaxing factor and coronary vasospasm.
Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm.
Endothelial dysfunction: the first step toward coronary arteriosclerosis.
Tako-tsubo-like left ventricular dysfunction with ST-segment elevation: a novel cardiac syndrome mimicking acute myocardial infarction.
Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels.
Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina.
T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm.
[Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases].
What is the best timing of surgery in patients with post-infarct ventricular septal rupture?
Urgent surgical repair of postinfarction ventricular septal rupture: early and late outcome.
Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction.
Transcatheter closure of a residual postmyocardial infarction ventricular septal defect with the Amplatzer septal occluder.
Relevance of delayed hospital admission on development of cardiac rupture during acute myocardial infarction: study in 225 patients with free wall, septal or papillary muscle rupture.
Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device.
Surgical repair of postinfarction ventricular septal defect by infarct exclusion.
Surgical repair of post-infarction ventricular septal defect: 19 years of experience.
Repair of postinfarction ventricular septal defects.
Postinfarction ventricular septal rupture: the Wessex experience.
Negative-pressure wound therapy following cardiac surgery: bleeding complications and 30-day mortality in 176 patients with deep sternal wound infection.
Increased pericardial fluid level of matrix metalloproteinase-9 activity in patients with acute myocardial infarction: possible role in the development of cardiac rupture.
Traumatic ventricular septal defect.
Repair of post-infarct ventricular septal defect with or without coronary artery bypass grafting in the northwest of England: a 5-year multi-institutional experience.
Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction.
Long term outcome of patients with postinfarction left ventricular pseudoaneurysm.
Ventricular septal rupture after acute myocardial infarction.
Surgical repair of ruptured interventricular septum following acute myocardial infarction.
Post infarction ventricular septal defect - can we do better?
Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?
Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.
Pulmonary arterial hypertension.
Treatment of pulmonary arterial hypertension.
Reversal of experimental pulmonary hypertension by PDGF inhibition.
Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis.
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.
Primary pulmonary hypertension. A national prospective study.
ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College...
Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.
Cellular and molecular pathobiology of pulmonary arterial hypertension.
Sildenafil citrate therapy for pulmonary arterial hypertension.